| Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort … A Marabelle, M Fakih, J Lopez, M Shah, R Shapira-Frommer, ... The Lancet Oncology 21 (10), 1353-1365, 2020 | 1636 | 2020 |
| Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1523 | 2017 |
| Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy S Kopetz, GJ Chang, MJ Overman, C Eng, DJ Sargent, DW Larson, ... Journal of clinical oncology 27 (22), 3677, 2009 | 1509 | 2009 |
| Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer L Amundadottir, P Kraft, RZ Stolzenberg-Solomon, CS Fuchs, ... Nature genetics 41 (9), 986-990, 2009 | 775 | 2009 |
| Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis SN Markovic, LA Erickson, RD Rao, RR McWilliams, LA Kottschade, ... Mayo Clinic Proceedings 82 (3), 364-380, 2007 | 769 | 2007 |
| Detectable clonal mosaicism and its relationship to aging and cancer KB Jacobs, M Yeager, W Zhou, S Wacholder, Z Wang, ... Nature genetics 44 (6), 651-658, 2012 | 665 | 2012 |
| A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22. 1, 1q32. 1 and 5p15. 33 GM Petersen, L Amundadottir, CS Fuchs, P Kraft, ... Nature genetics 42 (3), 224-228, 2010 | 639 | 2010 |
| Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer C Hu, SN Hart, EC Polley, R Gnanaolivu, H Shimelis, KY Lee, J Lilyquist, ... Jama 319 (23), 2401-2409, 2018 | 490 | 2018 |
| Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study F Meric-Bernstam, H Hurwitz, KPS Raghav, RR McWilliams, M Fakih, ... The Lancet Oncology 20 (4), 518-530, 2019 | 485 | 2019 |
| Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) AA Arslan, KJ Helzlsouer, C Kooperberg, XO Shu, E Steplowski, ... Archives of internal medicine 170 (9), 791-802, 2010 | 433 | 2010 |
| Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma MJ Borad, MD Champion, JB Egan, WS Liang, R Fonseca, AH Bryce, ... PLoS genetics 10 (2), e1004135, 2014 | 356 | 2014 |
| Non-V600BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer JC Jones, LA Renfro, HO Al-Shamsi, AB Schrock, A Rankin, BY Zhang, ... Journal of Clinical Oncology 35 (23), 2624, 2017 | 349 | 2017 |
| Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ... Annals of surgery 273 (2), 341-349, 2021 | 342 | 2021 |
| Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma RP Graham, EGB Fritcher, E Pestova, J Schulz, LA Sitailo, G Vasmatzis, ... Human pathology 45 (8), 1630-1638, 2014 | 315 | 2014 |
| BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study DB Zhen, KG Rabe, S Gallinger, S Syngal, AG Schwartz, MG Goggins, ... Genetics in Medicine 17 (7), 569-577, 2015 | 297 | 2015 |
| Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005) MM Corsini, RC Miller, MG Haddock, JH Donohue, MB Farnell, ... Journal of Clinical Oncology 26 (21), 3511-3516, 2008 | 297 | 2008 |
| A single-institution experience with 491 cases of small bowel adenocarcinoma TR Halfdanarson, RR McWilliams, JH Donohue, JF Quevedo The American journal of surgery 199 (6), 797-803, 2010 | 255 | 2010 |
| Long-term outcomes in patients with BRAF V600–mutant metastatic melanoma who received dabrafenib combined with trametinib GV Long, Z Eroglu, J Infante, S Patel, A Daud, DB Johnson, R Gonzalez, ... Journal of Clinical Oncology 36 (7), 667, 2018 | 243 | 2018 |
| Management of brain metastases from thyroid carcinoma: A study of 16 pathologically confirmed cases over 25 years RR McWilliams, C Giannini, ID Hay, JL Atkinson, SL Stafford, JC Buckner Cancer 98 (2), 356-362, 2003 | 232 | 2003 |
| Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor SJ Murphy, SN Hart, JF Lima, BR Kipp, M Klebig, JL Winters, C Szabo, ... Gastroenterology 145 (5), 1098-1109. e1, 2013 | 226 | 2013 |
